Login
Toggle navigation
Videos
Categories
Trending
"Factoring transforms invoices into immediate cash, offering fast payment solutions and benefits for trucking companies."
00:10:00
Watch Full Video
×
Please Login to watch Full video
Login
+ ADD TO Wishlist
×
Please login
Login
Share On Facebook
Share On Twitter
Alex Li · Founder/CEO at Apex Capital
Recent Videos
00:17:08
Urasar is 100% Hayasa Metals Inc. owned; our exploration license over the Urasar mineral district
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold 1
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
Suggestions
00:10:00
Personalized Team-Based Financial Guidance for Your Success
00:10:00
Cobalt Blue Holdings CEO Joe Kaderavek on Broken Hill Project and Strategic Partnerships.
00:10:00
Inside Kardex Mlog: 100 Years of Innovation and Future Plans | Felix Thöni - Chairperson of Kardex Group
00:10:00
Simteract’s Marcin Jaśkiewicz on the Impact of 'Taxi Life: A City Driving Simulator' Premiere | Marcin Jaśkiewicz, CEO, Simteract SA.
00:10:00
Unlocking the Potential of Generative AI in Healthcare: Expert Perspectives and Innovations | A. Hadi Chaudhry, CEO, CareCloud Inc.
00:10:00
The Operator Health Fund focuses on healthcare startups|Pascal Levy-Garboua,Venture Partner,Long Journey Ventures
00:10:00
Diversifying Revenue Streams and Adapting to Consumer Sophistication | Donald C Wood, CEO, Federal Realty Investment Trust.
00:10:00
Skyfii Ltd (ASX:SKF) CEO Wayne Arthur discusses the company's March quarterly highlights with Proactive, emphasizing their achievements in software technology.
00:10:00
Debut Capital helps their founders in product, tech stack strategy|Pilar Johnson,Co-Founder and Managing Partner,Debut Capital
00:10:00
Mithril Resources: Unveiling Promising Gold Discoveries in Serbia
00:10:00
Huntington Bancshares CEO Stephen Steinour discusses the bank's latest earnings and the impact of rising interest rates on regional banks on "Power Lunch."
00:10:00
humanity has advanced because the remarkable have pushed us forward|Angus Davis,General Partner,Foundation Capital